234 related articles for article (PubMed ID: 1871769)
1. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
[TBL] [Abstract][Full Text] [Related]
2. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
[TBL] [Abstract][Full Text] [Related]
3. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Burns LA; Sikorski EE; Saady JJ; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
[TBL] [Abstract][Full Text] [Related]
4. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
[TBL] [Abstract][Full Text] [Related]
6. Gallium arsenide exposure impairs processing of particulate antigen by macrophages: modification of the antigen reverses the functional defect.
Hartmann CB; McCoy KL
Life Sci; 2004 Jun; 75(4):485-98. PubMed ID: 15147834
[TBL] [Abstract][Full Text] [Related]
7. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
[TBL] [Abstract][Full Text] [Related]
8. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
Burns LA; Spriggs TL; Fuchs BA; Munson AE
J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
[TBL] [Abstract][Full Text] [Related]
9. Primary cellular target responsible for dimethylnitrosamine-induced immunosuppression in the mouse.
Johnson KW; Munson AE; Holsapple MP
Immunopharmacology; 1987 Feb; 13(1):47-60. PubMed ID: 2952621
[TBL] [Abstract][Full Text] [Related]
10. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
Lewis TA; Munson AE; McCoy KL
J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
[TBL] [Abstract][Full Text] [Related]
11. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
[TBL] [Abstract][Full Text] [Related]
12. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
Burns LA; Butterworth LF; Munson AE
J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene.
Ladics GS; Kawabata TT; Munson AE; White KL
Toxicol Appl Pharmacol; 1992 Oct; 116(2):258-66. PubMed ID: 1412470
[TBL] [Abstract][Full Text] [Related]
14. Respiratory exposure to diesel exhaust particles decreases the spleen IgM response to a T cell-dependent antigen in female B6C3F1 mice.
Yang HM; Butterworth L; Munson AE; Meade BJ
Toxicol Sci; 2003 Feb; 71(2):207-16. PubMed ID: 12563106
[TBL] [Abstract][Full Text] [Related]
15. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
Caffrey-Nolan RE; McCoy KL
Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the in vitro humoral immune response by chrysotile asbestos.
White KL; Munson AE
Toxicol Appl Pharmacol; 1986 Mar; 82(3):493-504. PubMed ID: 3952732
[TBL] [Abstract][Full Text] [Related]
17. Gallium arsenide exposure impairs splenic B cell accessory function.
Gondre-Lewis TA; Hartmann CB; Caffrey RE; McCoy KL
Int Immunopharmacol; 2003 Mar; 3(3):403-15. PubMed ID: 12639818
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of macrophage accessory cell function in casein-treated B6C3F1 mice.
Kaminski NE; Holsapple MP
J Immunol; 1987 Sep; 139(6):1804-10. PubMed ID: 3624870
[TBL] [Abstract][Full Text] [Related]
19. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
Burns LA; McCay JA; Brown R; Munson AE
J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
[TBL] [Abstract][Full Text] [Related]
20. Orally administered lactoferrin restores humoral immune response in immunocompromised mice.
Artym J; Zimecki M; Paprocka M; Kruzel ML
Immunol Lett; 2003 Oct; 89(1):9-15. PubMed ID: 12946859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
